NHANES has collected data on eating patterns, diabetes, and other common diseases for decades. The CDC team that runs it has ...

Biocryst Pharmaceuticals is acquiring Astria Therapeutics in a cash-and-stock deal with a $700 million enterprise value. The ...

Current and former FDA staff said the level of involvement of political officials in nitty-gritty regulatory matters is ...

A troubled Indiana contract manufacturing plant recently acquired by Novo Nordisk is considered to not be in compliance with ...

Lyra Health has launched a "clinical-grade" chatbot amid growing concern about mental health and artificial intelligence.

Robert F. Kennedy Jr.’s tenure atop HHS has been marked by increasing tension between career scientists and political leaders ...

Animals used in research aren’t just hidden from sight. They’re objectified, or “de-animalized,” as Melanie D.G. Kaplan ...

Welcome to Neurotransmissions, a new First Opinion column on the revolution in dementia. This is the second in a three-part ...

The FDA has declared a Novo Nordisk plant, key to drug manufacturing for some biotechs, out of compliance, which could delay ...

How a company treats its clinical trial pioneers is a litmus test for corporate social responsibility,” writes Nkarta CEO ...